company background image
A180400 logo

Dx & Vx KOSDAQ:A180400 Stock Report

Last Price

₩1.80k

Market Cap

₩91.9b

7D

1.5%

1Y

-69.6%

Updated

26 Dec, 2024

Data

Company Financials

A180400 Stock Overview

Engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea. More details

A180400 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Dx & Vx Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Dx & Vx
Historical stock prices
Current Share Price₩1,798.00
52 Week High₩7,280.00
52 Week Low₩1,520.00
Beta-0.0042
1 Month Change-5.57%
3 Month Change-33.41%
1 Year Change-69.58%
3 Year Changen/a
5 Year Changen/a
Change since IPO-62.85%

Recent News & Updates

Dx & Vx Co., Ltd. (KOSDAQ:180400) Might Not Be As Mispriced As It Looks After Plunging 28%

Dec 05
Dx & Vx Co., Ltd. (KOSDAQ:180400) Might Not Be As Mispriced As It Looks After Plunging 28%

Positive Sentiment Still Eludes Dx & Vx Co., Ltd. (KOSDAQ:180400) Following 27% Share Price Slump

Oct 21
Positive Sentiment Still Eludes Dx & Vx Co., Ltd. (KOSDAQ:180400) Following 27% Share Price Slump

Recent updates

Dx & Vx Co., Ltd. (KOSDAQ:180400) Might Not Be As Mispriced As It Looks After Plunging 28%

Dec 05
Dx & Vx Co., Ltd. (KOSDAQ:180400) Might Not Be As Mispriced As It Looks After Plunging 28%

Positive Sentiment Still Eludes Dx & Vx Co., Ltd. (KOSDAQ:180400) Following 27% Share Price Slump

Oct 21
Positive Sentiment Still Eludes Dx & Vx Co., Ltd. (KOSDAQ:180400) Following 27% Share Price Slump

Market Cool On Dx & Vx Co., Ltd.'s (KOSDAQ:180400) Revenues Pushing Shares 39% Lower

Jul 15
Market Cool On Dx & Vx Co., Ltd.'s (KOSDAQ:180400) Revenues Pushing Shares 39% Lower

Dx & Vx Co., Ltd. (KOSDAQ:180400) Might Not Be As Mispriced As It Looks After Plunging 37%

May 31
Dx & Vx Co., Ltd. (KOSDAQ:180400) Might Not Be As Mispriced As It Looks After Plunging 37%

Investors Give Dx & Vx Co., Ltd. (KOSDAQ:180400) Shares A 25% Hiding

Mar 18
Investors Give Dx & Vx Co., Ltd. (KOSDAQ:180400) Shares A 25% Hiding

Dx & Vx (KOSDAQ:180400) Is Carrying A Fair Bit Of Debt

Mar 08
Dx & Vx (KOSDAQ:180400) Is Carrying A Fair Bit Of Debt

Shareholder Returns

A180400KR BiotechsKR Market
7D1.5%-2.3%-1.9%
1Y-69.6%14.9%-9.5%

Return vs Industry: A180400 underperformed the KR Biotechs industry which returned 14.9% over the past year.

Return vs Market: A180400 underperformed the KR Market which returned -9.5% over the past year.

Price Volatility

Is A180400's price volatile compared to industry and market?
A180400 volatility
A180400 Average Weekly Movement9.5%
Biotechs Industry Average Movement8.8%
Market Average Movement6.6%
10% most volatile stocks in KR Market12.8%
10% least volatile stocks in KR Market3.3%

Stable Share Price: A180400's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A180400's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
2001112Yong Gu Leewww.dxvx.com

Dx & Vx Co., Ltd. engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea. The company offers healthcare products, including Ofmom Carefree, oat fermented food, and biocleaners; diagnostic products, comprising CLIDEX, precision diagnostics, and in vitro diagnostic kit; health check services; CDx development services; medical data; and funeral home operation services. It provides bacterial vaccine for respiratory disease; macular degeneration drug; atopy dermatitis drugs; xeropthalmia drugs; anticancer vaccine; and new antibody drugs.

Dx & Vx Co., Ltd. Fundamentals Summary

How do Dx & Vx's earnings and revenue compare to its market cap?
A180400 fundamental statistics
Market cap₩91.94b
Earnings (TTM)-₩32.63b
Revenue (TTM)₩42.30b

2.1x

P/S Ratio

-2.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A180400 income statement (TTM)
Revenue₩42.30b
Cost of Revenue₩33.21b
Gross Profit₩9.09b
Other Expenses₩41.72b
Earnings-₩32.63b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-662.95
Gross Margin21.49%
Net Profit Margin-77.13%
Debt/Equity Ratio82.0%

How did A180400 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 09:42
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dx & Vx Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution